10X GENOMICS INC's ticker is TXG and the CUSIP is 88025U109. A total of 306 filers reported holding 10X GENOMICS INC in Q4 2020. The put-call ratio across all filers is 0.38 and the average weighting 1.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $744,000 | -50.3% | 9,786 | -2.7% | 0.00% | – |
| Q4 2021 | $1,498,000 | +0.3% | 10,056 | -1.9% | 0.00% | – |
| Q3 2021 | $1,493,000 | -25.6% | 10,255 | 0.0% | 0.00% | – |
| Q2 2021 | $2,008,000 | +7.2% | 10,255 | -0.9% | 0.00% | – |
| Q1 2021 | $1,874,000 | +30.0% | 10,352 | +1.7% | 0.00% | – |
| Q4 2020 | $1,442,000 | +13.3% | 10,181 | -0.2% | 0.00% | – |
| Q3 2020 | $1,273,000 | +53.0% | 10,203 | +9.5% | 0.00% | – |
| Q2 2020 | $832,000 | +46.0% | 9,316 | +1.9% | 0.00% | – |
| Q1 2020 | $570,000 | -18.5% | 9,146 | -0.3% | 0.00% | – |
| Q4 2019 | $699,000 | -81.7% | 9,169 | -87.9% | 0.00% | -100.0% |
| Q3 2019 | $3,812,000 | – | 75,627 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Venrock Management VI, LLC | 962,309 | $188,439,000 | 95.08% |
| Foresite Capital Management II, LLC | 1,753,528 | $343,376,000 | 92.37% |
| Foresite Capital Management I, LLC | 750,000 | $146,865,000 | 88.53% |
| 12 West Capital Management LP | 1,922,000 | $376,366,000 | 15.78% |
| Financial Consulate Inc. | 141,258 | $27,661,000 | 9.97% |
| FINANCIAL CONSULATE, INC | 141,258 | $27,661,000 | 9.97% |
| Meritech Capital Associates V L.L.C. | 1,793,871 | $351,276,000 | 7.51% |
| Andar Capital Management HK Ltd | 51,000 | $9,987,000 | 6.81% |
| JS Capital Management LLC | 540,589 | $105,858,000 | 5.12% |
| Renaissance Capital LLC | 97,281 | $19,050,000 | 3.01% |